Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Debt (2019 - 2025)

Pulmonx (LUNG) has disclosed Total Debt for 7 consecutive years, with $37.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Debt changed 0.28% to $37.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $37.1 million, a 0.28% change, with the full-year FY2024 number at $37.2 million, changed 0.18% from a year prior.
  • Total Debt was $37.1 million for Q3 2025 at Pulmonx, roughly flat from $37.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $37.3 million in Q1 2023 to a low of $270000.0 in Q4 2021.
  • A 5-year average of $25.6 million and a median of $37.1 million in 2025 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: soared 6316.3% in 2022, then decreased 0.28% in 2025.
  • Pulmonx's Total Debt stood at $270000.0 in 2021, then skyrocketed by 6316.3% to $17.3 million in 2022, then skyrocketed by 114.98% to $37.2 million in 2023, then fell by 0.18% to $37.2 million in 2024, then fell by 0.13% to $37.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Total Debt are $37.1 million (Q3 2025), $37.1 million (Q2 2025), and $37.2 million (Q1 2025).